by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H

Slides:

Advertisements

Similar presentations

1 Background Hypertension Type 2 diabetes Coronary heart disease Gallbladder disease Certain cancers Dyslipidemia Stroke Osteoarthritis Sleep apnea Approximately.

Advertisements

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Blood samples available from study participants with myocardial infarction and controls by ethnic origin Matthew J McQueen, et al. Lancet 2008; 372:

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:

WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.

Trial profile Prakash Deedwania, et al. Lancet 2006; 368:

Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

by , Rita F. Redberg, Emelia J. Benjamin, Vera Bittner, Lynne T

Michael J. Koren, MD, Michael H. Davidson, MD, Daniel J

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality Rishi K. Wadhera,

Kerry-Anne Rye, Kwok Leung Ong The Lancet Diabetes & Endocrinology

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Copyright © 2001 American Medical Association. All rights reserved.

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

Clinical Characteristics

HDL cholesterol and cardiovascular risk Epidemiological evidence

Copyright © 2012 American Medical Association. All rights reserved.

by Qi Sun, Monik C. Jiménez, Mary K. Townsend, Eric B. Rimm, JoAnn E

Association of blood lipids with AF

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol by Allan.

Arterioscler Thromb Vasc Biol

Persistent High Serum Bicarbonate and the Risk of Heart Failure in Patients With Chronic Kidney Disease (CKD): A Report From the Chronic Renal Insufficiency.

Body Mass Index, Sex, and Cardiovascular Disease Risk Factors Among Hispanic/Latino Adults: Hispanic Community Health Study/Study of Latinos by Robert.

TNT: Baseline and final LDL cholesterol levels

Behavior and Biology: The Basic Sciences for AHA Action

Risk Factors for Rehospitalization for Acute Coronary Syndromes and Unplanned Revascularization Following Acute Myocardial Infarction by Suzanne V. Arnold,

Ahead of the Curve by Alun D. Hughes Hypertension Volume 64(5):

25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study by Erin D. Michos,

Prospective associations of plasma phospholipid trans/trans-18:2 with total mortality, CVD and CHD before and after mutual adjustment without correction.

Prediction of Cardiovascular Disease by the Framingham‐REGICOR Equation in the High‐Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different.

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Figure 7 Mendelian randomization of overlapping exposures

by Nadine Martel, James Lee, and Philip S. Wells

James H. O’Keefe, MD, Salman K. Bhatti, MD, Ata Bajwa, MD, James J

Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study Dr Danish Saleheen, PhD,

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Effect of evolocumab on lipoprotein particles

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality Rishi K. Wadhera,

Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:

Jonathan C. Cohen, PhD Journal of Clinical Lipidology

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

Primary and Secondary Prevention of Cardiovascular Disease

APOC3, Coronary Disease, and Complexities of Mendelian Randomization

Description of studies for pooled analyses

Kerry-Anne Rye, Kwok Leung Ong The Lancet Diabetes & Endocrinology

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Association between Nonalcoholic Fatty Liver Disease at CT and Coronary Microvascular Dysfunction at Myocardial Perfusion PET/CT Coronary microvascular.

David J.A. Jenkins et al. JACC 2018;71:

Screening, enrollment, and randomization of study participants (BMI, body mass index; CTG, conventional therapy group; HbA1c, glycated hemoglobin; HDL-C,

The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis Moritz C. Wyler von Ballmoos, MD, MPH, Bernhard.

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Cause of death Treatment-arm events, % (n=45 054)

Baseline Characteristics

Age-specific mortality rates from CHD and stroke in women and men in 2010 in selected countries. Age-specific mortality rates from CHD and stroke in women.

Glycated Hemoglobin Levels (A1C)

Characteristics of included studies

Receiver operating curves (ROC) of simple age and gender adjusted risk factor models for predicting 10-year risk of cardiovascular disease comparing the.

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm

Change in markers of glycometabolism and cardiovascular risk profile.

Adjusted relative risk Adjusted odds ratio

Occupational Life Expectancy in England & Wales,

Increase of physical activity over time associated with lower HF risk

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Hazard ratios, with 95% confidence intervals as floating absolute risks, as estimate of association between category of updated mean haemoglobin A1c concentration.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H. Criqui, Lihui Zhao, Philip Greenland, and Donald M. Lloyd-Jones J Am Heart Assoc Volume 3(2):e000519 April 22, 2014 © 2014 John T. Wilkins et al.

Log hazard ratios (95% CI) for CHD events by HDL-C for men and women. Log hazard ratios (95% CI) for CHD events by HDL-C for men and women. CHD indicates coronary heart disease; HDL-C, high-density lipoprotein cholesterol. John T. Wilkins et al. J Am Heart Assoc 2014;3:e000519 © 2014 John T. Wilkins et al.